The setup for Q4. Chicago Atlantic BDC, Inc. (NASDAQ: LIEN) reports fourth-quarter fiscal 2025 results before the market opens on March 19, followed by a conference call at 9:00 AM ET. Wall Street consensus data points to EPS of $0.36 on revenue of $13.41 million. The company posted EPS of $0.35 in the year-ago Q4 2024 period. Revenue reached $12.65 million in Q4 2024, providing a baseline for sequential and year-over-year comparisons.
What matters most for this BDC. As a business development company focused on the cannabis ecosystem, investors will scrutinize net investment income trends and portfolio credit quality. The company’s ability to maintain or grow its dividend—critical for BDC investors—depends on stable interest income from its loan portfolio and controlled credit losses. Any updates on portfolio composition, non-accrual loans, or new originations will signal whether the cannabis lending environment is stabilizing or deteriorating. Net asset value per share movement will also be closely watched, as it reflects the mark-to-market health of the underlying investments.
Recent execution has been mixed. Chicago Atlantic delivered EPS of $0.42 in Q3 2025, topping the $0.35 estimate by 20%. But the prior two quarters showed misses: Q2 2025 EPS of $0.34 fell 5.6% short of the $0.36 consensus, and Q1 2025’s $0.33 missed the $0.34 estimate by 2.9%. The Q3 beat suggests improving fundamentals, but the inconsistent pattern leaves the bar uncertain heading into Q4.
Estimate momentum shows modest upward drift. For the full fiscal year 2025, the consensus EPS estimate stands at $1.45, up from $1.41 a week ago—a single upward revision in the past seven days. Looking ahead to Q1 2026, the $0.36 EPS estimate has moved lower from $0.37 over the past week, reflecting one downward revision. The modest adjustments suggest analysts are fine-tuning expectations rather than making major calls on the business trajectory.
Analyst sentiment remains constructive. Zuanic & Associates initiated coverage with an Overweight rating on May 23, 2025, while Oppenheimer initiated at Perform on April 22, 2025. Neither firm disclosed a price target in the available data. The Overweight rating signals confidence in the BDC’s risk-adjusted return profile, though the limited analyst coverage—typical for smaller BDCs—means consensus views may not fully capture the stock’s risk/reward setup.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.